New research shows that dairy cows develop an immunity to High-Path Avian Flu (HPAI) after initial infections.
The breakthrough comes after cows exposed through an initial infection showed signs of protection against a secondary exposure. Cows exposed for a second time showed no signs of disease. Their milk production remained steady, and the virus was undetectable.
Researchers at the University of Saskatchewan say their study suggests that a vaccine could be highly effective in managing outbreaks. However, they note differences between infection and vaccination and say that more research is needed.
Related Stories
Highly Pathogenic Avian Flu (HPAI) cases are rising. In the last week, seven commercial turkey, duck, and egg layer flocks were culled across five Midwest states and California.
The Sheinbaum–Rollins meeting signals progress, but the focus remains on fully containing screwworm before cross-border movement resumes.
Livestock profits are propping up overall sentiment, but crop producers remain cautious amid tight margins and uncertain policy signals.
RaboResearch says China’s pivot from mass production to innovation-driven growth could reshape global pesticide supply chains — and influence prices and product access for U.S. farmers in the coming years.
Recent U.S.–China trade developments provided a small lift for soy markets, though most traders are waiting for concrete purchase data before making major moves.
Expect modest relief on several produce lines, mixed protein trends into holiday buying, and softer veg-oil costs — a good week to sharpen forward buys selectively.
RFD-TV’s farm legal expert, Roger McEowen, digs into the details of both the LRP and the LGM programs, two essential risk management tools for cattle producers.
According to the new report, seven out of ten rural bankers support President Trump’s recent trade steps with China, expressing cautious optimism about future export potential.
An import lag for ground beef will likely look different than last year’s egg shortage. The difference comes down to biosecurity and market flexibility.
